Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
they help reset your relationship with food and improve overall health from the inside out
They have demonstrated significant benefits in weight reduction, glycemic control, and cardiovascular health
Including specific clinical trial data showing the efficacy of the prescribed GLP-1 medication for patients with your BMI range and comorbidities strengthens the case considerably
00:08:35 Vickie Danaher When it comes to dosing, like the other GLP-1 agonists, orforglipron is started low and titrated monthly to improve tolerability
Here, we used the US Department of Veterans Affairs databases to build a cohort of people with diabetes who initiated GLP-1RA ( n = 215,970) and compared them to those who initiated sulfonylureas ( n = 159,465), dipeptidyl peptidase 4 (DPP4) inhibitors ( n = 117,989) or sodiumglucose cotransporter-2 (SGLT2) inhibitors ( n = 258,614), a control group composed of an equal proportion of individuals initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors ( n = 536,068), and a control group of 1,203,097 individuals who continued use of non-GLP-1RA antihyperglycemics (usual care)
)
